Ajim Tamboli insider trades

Open-market stock purchases and sales by Ajim Tamboli, Chief Financial Officer at First Tracks Biotherapeutics, Inc, from SEC Form 4 filings since Apr 12, 2021.

Recent trades

DateStockTradeValue
May 12, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
May 12, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 23, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 22, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 21, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 21, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—

Companies traded

  • TRAX First Tracks Biotherapeutics, Inc: other filings, last May 12, 2026
  • GLUE Monte Rosa Therapeutics, Inc: other filings, last Jan 3, 2023

Get free alerts when Ajim Tamboli files a new trade →